2nd International Conference on Hematology and Oncology
August 23-24, 2018 | London, UK
Keynote
- 
                Evaluation of classical and novel von Willebrand Factor assays in ECLM defined von Willebrand disease patientsHematol Blood Disord Jan Michiels
- 
                Hematopoietic cell transplantation for myelodysplastic syndrome and myeloproliferative neoplasms: issues of age, ethics, and uncertaintyHematol Blood Disord H Joachim Deeg